ETHZilla to Tokenize $4.7M Pool of 95 Manufactured Home Loans on Ethereum L2
- ETHZilla bought 95 manufactured/modular home loans and first‑lien mortgages for about $4.7 million via a new subsidiary.
- ETHZilla will tokenize the loan pool on an Ethereum Layer‑2 network for on‑chain tracking and automated cash‑flow distribution.
- ETHZilla frames the portfolio as recurring cash‑flow credit, expecting roughly a 10.36% annualized yield from contractual interest.
New manufactured‑home loan pool moves toward on‑chain issuance
Tokenizing 95 manufactured and modular home loans on Ethereum Layer 2
ETHZilla acquires 95 manufactured and modular home loans and the first‑lien mortgages securing them through its newly formed subsidiary, ETHZilla Modular Mortgage LLC, in a deal worth approximately $4.7 million. The company plans to tokenize the seasoned residential credit pool on an Ethereum Layer 2 network to enable on‑chain asset tracking and automated cash‑flow distribution. ETHZilla schedules an intended token launch through the Liquidity.io ecosystem in late February or early March, positioning the offering as a cash‑flow‑generating manufactured home loan token for institutional and accredited investors.
The loans remain serviced by Zippy Loans LLC under the existing servicing arrangement, keeping origination and day‑to‑day loan administration with an experienced operator while ETHZilla brings the assets on chain. ETHZilla frames the portfolio as a recurring cash‑flow credit pool that generates contractual interest payments and expects an annualized yield of about 10.36% from those cash flows. The company emphasizes that tokenization will provide transparent, auditable payment flows and automated distributions via smart contracts, reducing reconciliation friction for secondary market participation.
ETHZilla portrays the transaction as a repeatable element of a broader strategy to tokenize differentiated real‑world assets across sectors. The deal follows a recent acquisition of two leased CFM56‑7B24 aircraft engines that the company also intends to tokenize and list on Liquidity.io, illustrating a template the firm is developing to convert established, income‑producing assets into tradable on‑chain instruments. ETHZilla seeks to combine asset‑level expertise, servicing relationships and blockchain infrastructure to scale offerings across multiple asset classes.
Deal economics and servicing
The company acquires the loan pool from Zippy Manufactured Home Credit Fund I L.P., while retaining Zippy Loans LLC as servicer; ETHZilla reports the portfolio is seasoned and expected to deliver roughly a 10.36% annualized yield from contractual interest. ETHZilla emphasizes the modest purchase price relative to expected cash flows and the operational continuity provided by the existing servicer.
Strategic context and partnerships
ETHZilla builds on a prior investment that gives it roughly 15% of fully diluted ownership in Zippy, Inc., the fund’s parent, strengthening access to origination and servicing expertise. Chairman and CEO McAndrew Rudisill describes the move as a disciplined extension of the company’s approach to bringing cash‑flow‑generating assets on‑chain within regulated, transparent structures.
Related Cashu News

CRISPR Therapeutics AG Achieves Financial Progress Amid Advancements in Gene-Editing Portfolio
CRISPR Therapeutics AG (Ticker: UNDEFINED) showcases a pivotal moment in its financial journey with the release of its results for the first quarter of 2026. Highlighting a revenue of $1.46 million, t…

MetaVia to Present Innovative Cardiometabolic Research at 2026 ADA Scientific Sessions
MetaVia is set to showcase its innovative research in cardiometabolic diseases at the upcoming American Diabetes Association (ADA) Scientific Sessions in 2026, following the acceptance of three late-b…

Ionis Pharmaceuticals Advances TRYNGOLZA for Hypertriglyceridemia and Diranersen for Alzheimer's Disease
Ionis Pharmaceuticals has made headlines in the biotechnology sector with the promising potential of its drug TRYNGOLZA, which is designed to treat severe hypertriglyceridemia. During a recent healthc…

ImmunityBio Partners with BCG Laboratory to Enhance Bladder Cancer Treatment Supply and Options
ImmunityBio has secured a critical partnership with Japan's BCG Laboratory to enhance the supply of Bacillus Calmette-Guérin (BCG) in the United States, addressing an urgent need in the treatment of b…